101. Prevalence and Correlates of Low Medication Adherence in Apparent Treatment-Resistant Hypertension
- Author
-
Daniel T. Lackland, David A. Calhoun, Marie Krousel-Wood, Nita A. Limdi, Marguerite R. Irvin, Kristi Reynolds, Devin M. Mann, Suzanne Oparil, Paul Muntner, and Daichi Shimbo
- Subjects
medicine.medical_specialty ,education.field_of_study ,High prevalence ,business.industry ,Endocrinology, Diabetes and Metabolism ,Population ,Medication adherence ,medicine.disease ,Coronary heart disease ,Internal medicine ,Internal Medicine ,Physical therapy ,Medicine ,Cardiology and Cardiovascular Medicine ,business ,education ,Treatment resistant ,Stroke ,Stroke Belt ,Biomedical sciences - Abstract
Low medication adherence may explain part of the high prevalence of apparent treatment-resistant hypertension (aTRH). The authors assessed medication adherence and aTRH among 4026 participants taking ≥ 3 classes of antihypertensive medication in the population-based Reasons for Geographic and Racial Differences in Stroke (REGARDS) trial using the 4-item Morisky Medication Adherence Scale (MMAS). Low adherence was defined as an MMAS score ≥ 2. Overall, 66% of participants taking ≥ 3 classes of antihypertensive medication had aTRH. Perfect adherence on the MMAS was reported by 67.8% and 70.9% of participants with and without aTRH, respectively. Low adherence was present among 8.1% of participants with aTRH and 5.0% of those without aTRH (P
- Published
- 2012